ESKETAMINE HYDROCHLORIDE NASAL SPRAY (Spravato®)

Clinical Indication

In combination with a SSRI or SNRI for adults with treatment-resistant Major Depressive Disorder

Comments

Administration in specialist clinic only

Date of classification

June 2020

Review date

August 2021

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.